news

Feb 15 2017
TapImmune Advances TPIV 200 Phase 2 Triple-Negative Breast Cancer Trial After Favorable DSMB Safety Review

Feb 14 2017
Ehave and MedReleaf Enter Partnership to Optimize the Therapeutic Potential of Medical Cannabis Products

Feb 7 2017
KemPharm to Present at Upcoming Investor Conferences


 

events

Feb 15-16 2017
Leerink Partners Global Healthcare Conference

Feb 21-22 2017
RBC Capital Markets Global Healthcare Conference

Mar 6-8 2017
Cowen & Co. Health Care Conference

Mar 12-15 2017
ROTH Conference


 

spotlight